HomeCompareRRETY vs PFE

RRETY vs PFE: Dividend Comparison 2026

RRETY yields 5.68% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RRETY wins by $12765.47M in total portfolio value
10 years
RRETY
RRETY
● Live price
5.68%
Share price
$6.36
Annual div
$0.36
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$12765.52M
Annual income
$12,347,757,806.19
Full RRETY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — RRETY vs PFE

📍 RRETY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRRETYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RRETY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RRETY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RRETY
Annual income on $10K today (after 15% tax)
$482.63/yr
After 10yr DRIP, annual income (after tax)
$10,495,594,135.26/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, RRETY beats the other by $10,495,571,815.36/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RRETY + PFE for your $10,000?

RRETY: 50%PFE: 50%
100% PFE50/50100% RRETY
Portfolio after 10yr
$6382.78M
Annual income
$6,173,892,032.46/yr
Blended yield
96.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

RRETY
No analyst data
Altman Z
2.2
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RRETY buys
0
PFE buys
0
No recent congressional trades found for RRETY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRRETYPFE
Forward yield5.68%6.13%
Annual dividend / share$0.36$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%13.2%
Portfolio after 10y$12765.52M$49.6K
Annual income after 10y$12,347,757,806.19$26,258.71
Total dividends collected$12736.47M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RRETY vs PFE ($10,000, DRIP)

YearRRETY PortfolioRRETY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,836$1,135.61$9,153$693.39+$2.7KRRETY
2$15,176$2,512.27$8,593$849.25+$6.6KRRETY
3$22,260$6,021.29$8,336$1,066.78+$13.9KRRETY
4$40,326$16,507.95$8,437$1,384.80+$31.9KRRETY
5$99,048$55,898.58$9,013$1,875.40+$90.0KRRETY
6$362,609$256,627.97$10,306$2,680.72+$352.3KRRETY
7$2,144,074$1,756,082.17$12,820$4,101.38+$2.13MRRETY
8$21,702,675$19,408,516.50$17,673$6,826.70+$21.69MRRETY
9$390,429,861$367,207,998.06$27,543$12,591.86+$390.40MRRETY
10$12,765,517,757$12,347,757,806.19$49,560$26,258.71+$12765.47MRRETY

RRETY vs PFE: Complete Analysis 2026

RRETYStock

Robinsons Retail Holdings, Inc. operates as a multi-format retail company in the Philippines. The company operates through Supermarkets, Department Stores, DIY Stores, Convenience Stores, Drug Stores, and Specialty Stores segments. It operates supermarkets under the Robinsons Supermarket brand that offer health and wellness, and fresh food products; and department stores under the Robinsons Department Store brand, which provide children's apparel, accessories; homes, snacks and stationery; shoes, bags, luggage and sportswear; ladies and men's apparel, beauty accessories, and furnishings. The company also operates do-it-yourself (DIY) stores under the Handyman Do it Best, True Value, True Home, Robinsons Builders, Home Plus, De Oro Pacific Home Plus, and A.M. Builders' Depot brands that offer DIY and home improvement products; operates and franchises convenience stores under the Ministop name that provide fresh and ready to eat products; and operates drug stores under the South Star Drug name that offer prescription and over-the-counter pharmaceutical products, as well as food, personal care, and other products. In addition, it operates toys and juvenile products under Toys 'R' Us name; consumer electronics and appliances stores under Robinsons Appliances and Saver's Appliance name; beauty products under the Benefit, Shiseido, and Elizabeth Arden brands; mass merchandise stores under the Daiso Japan, Arcova, and Super50 name; pet retail under the Pet Lovers Centre name; and discount store under the No Brand name. It operates 2,208 stores, including 286 supermarkets, 52 department stores, 227 DIY stores, 456 convenience stores, 899 drug stores, and 288 specialty stores. Robinsons Retail Holdings, Inc. was founded in 1980 and is headquartered in Pasig City, the Philippines.

Full RRETY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this RRETY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RRETY vs SCHDRRETY vs JEPIRRETY vs ORRETY vs KORRETY vs MAINRRETY vs JNJRRETY vs MRKRRETY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.